These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33760984)

  • 1. High KIFC1 expression is associated with poor prognosis in prostate cancer.
    Kostecka LG; Olseen A; Kang K; Torga G; Pienta KJ; Amend SR
    Med Oncol; 2021 Mar; 38(5):47. PubMed ID: 33760984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.
    Mittal K; Choi DH; Klimov S; Pawar S; Kaur R; Mitra AK; Gupta MV; Sams R; Cantuaria G; Rida PCG; Aneja R
    J Ovarian Res; 2016 Mar; 9():17. PubMed ID: 26992853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.
    Pawar S; Donthamsetty S; Pannu V; Rida P; Ogden A; Bowen N; Osan R; Cantuaria G; Aneja R
    J Ovarian Res; 2014; 7():53. PubMed ID: 25028599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell.
    Parvin A; Hao SL; Tan FQ; Yang WX
    Gene; 2020 Nov; 760():144989. PubMed ID: 32717307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of kinesin family member C1 in pancreatic ductal adenocarcinoma affects tumor progression and stemness.
    Ishikawa A; Fujii H; Fukui T; Kido A; Katsuya N; Sentani K; Kuraoka K; Tazuma S; Sudo T; Serikawa M; Oka S; Oue N
    Pathol Res Pract; 2023 Jan; 241():154277. PubMed ID: 36565617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
    Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L
    Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers.
    Jinna N; Yuan YC; Rida P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression levels of AURKA and KIFC1 are promising predictors of progression and poor survival associated with gastric cancer.
    Jung J; Jeong H; Choi JW; Kim HS; Oh HE; Lee ES; Kim YS; Lee JH
    Pathol Res Pract; 2021 Aug; 224():153524. PubMed ID: 34148003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer.
    Sekino Y; Oue N; Shigematsu Y; Ishikawa A; Sakamoto N; Sentani K; Teishima J; Matsubara A; Yasui W
    Urol Oncol; 2017 Jan; 35(1):31.e13-31.e20. PubMed ID: 27665358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIFC1 regulates ZWINT to promote tumor progression and spheroid formation in colorectal cancer.
    Akabane S; Oue N; Sekino Y; Asai R; Thang PQ; Taniyama D; Sentani K; Yukawa M; Toda T; Kimura KI; Egi H; Shimizu W; Ohdan H; Yasui W
    Pathol Int; 2021 Jul; 71(7):441-452. PubMed ID: 33819373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer.
    Zhang S; Qin O; Xu H; Wu S; Huang W; Song H
    Aging (Albany NY); 2023 Dec; 15(24):14845-14863. PubMed ID: 38112634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
    Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
    Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway.
    Zhou K; Zhao J; Qi L; He Y; Xu J; Dai M
    Technol Cancer Res Treat; 2020; 19():1533033820964217. PubMed ID: 33034273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
    Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
    Qureshi Z; Ahmad M; Yang WX; Tan FQ
    Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role for KIFC1-MYH9 interaction in triple-negative breast cancer aggressiveness and racial disparity.
    Garlapati C; Joshi S; Yang C; Chandrashekar DS; Rida P; Aneja R
    Cell Commun Signal; 2024 Jun; 22(1):312. PubMed ID: 38902769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.
    Sun Y; Zhang Y; Lang Z; Huang J; Zou Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17346. PubMed ID: 31577729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway.
    Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
    Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.
    Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y
    Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
    Chen C; Cai Z; Zhuo Y; Xi M; Lin Z; Jiang F; Liu Z; Wan Y; Zheng Y; Li J; Zhou X; Zhu J; Zhong W
    BMC Cancer; 2020 Apr; 20(1):289. PubMed ID: 32252682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.